1. Home
  2. DVA vs FUTU Comparison

DVA vs FUTU Comparison

Compare DVA & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • FUTU
  • Stock Information
  • Founded
  • DVA 1994
  • FUTU 2011
  • Country
  • DVA United States
  • FUTU Hong Kong
  • Employees
  • DVA N/A
  • FUTU N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • FUTU Investment Bankers/Brokers/Service
  • Sector
  • DVA Health Care
  • FUTU Finance
  • Exchange
  • DVA Nasdaq
  • FUTU Nasdaq
  • Market Cap
  • DVA 12.2B
  • FUTU 12.7B
  • IPO Year
  • DVA 1995
  • FUTU 2019
  • Fundamental
  • Price
  • DVA $165.51
  • FUTU $84.22
  • Analyst Decision
  • DVA Hold
  • FUTU Buy
  • Analyst Count
  • DVA 5
  • FUTU 7
  • Target Price
  • DVA $153.40
  • FUTU $75.79
  • AVG Volume (30 Days)
  • DVA 1.0M
  • FUTU 3.3M
  • Earning Date
  • DVA 10-29-2024
  • FUTU 11-19-2024
  • Dividend Yield
  • DVA N/A
  • FUTU N/A
  • EPS Growth
  • DVA 41.03
  • FUTU 2.20
  • EPS
  • DVA 9.24
  • FUTU 4.09
  • Revenue
  • DVA $12,666,614,000.00
  • FUTU $1,307,165,497.00
  • Revenue This Year
  • DVA $6.17
  • FUTU $29.76
  • Revenue Next Year
  • DVA $3.56
  • FUTU $15.21
  • P/E Ratio
  • DVA $17.90
  • FUTU $20.60
  • Revenue Growth
  • DVA 6.34
  • FUTU 11.68
  • 52 Week Low
  • DVA $98.26
  • FUTU $43.61
  • 52 Week High
  • DVA $168.50
  • FUTU $130.50
  • Technical
  • Relative Strength Index (RSI)
  • DVA 62.72
  • FUTU 42.24
  • Support Level
  • DVA $154.05
  • FUTU $86.58
  • Resistance Level
  • DVA $161.80
  • FUTU $93.66
  • Average True Range (ATR)
  • DVA 4.24
  • FUTU 5.23
  • MACD
  • DVA 1.71
  • FUTU -1.58
  • Stochastic Oscillator
  • DVA 96.71
  • FUTU 9.45

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About FUTU Futu Holdings Limited

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Share on Social Networks: